Abstract
Co-exposure to heavy metals can result in additive or synergistic toxicity in the brain, culminating in neurotoxicity. This study investigated the neurotoxic effects of a low-dose mixture of two toxic heavy metals—lead (Pb, 20 mg/kg) and aluminium (Al, 35 mg/kg)—and one essential metal, manganese (Mn, 0.564 mg/kg), on the cerebellum of rats. Animals were divided into five groups (n = 5) and orally treated for 90 days as follows: Group I received normal drinking water and served as the control; Group II received a heavy metal mixture of Pb (20 mg/kg), Al (35 mg/kg), and Mn (0.564 mg/kg) body weight; Group III received Pb (20 mg/kg) alone; Group IV received Al (35 mg/kg) alone; and Group V received Mn (0.564 mg/kg) alone. Chronic exposure to heavy metals resulted in a significant (p < 0.05) reduction in rotarod performance compared with the control group, indicating impaired cerebellar motor function. The low-dose heavy metal mixture significantly depressed antioxidant defences (p < 0.05), increased lipid peroxidation (p < 0.05), elevated amyloid-β peptide levels (Aβ₁–₄₀ and Aβ₁–₄₂) (p < 0.05), and markedly reduced occludin expression (p < 0.05) in the cerebellum relative to controls. These biochemical alterations were more pronounced in the mixture-exposed group than in animals treated with individual metals. Overall, chronic low-dose exposure to an environmentally relevant heavy metal mixture induces cerebellar neurotoxicity through enhanced amyloid-β accumulation and downregulation of occludin, a key tight junction protein, in adult male Wistar rats. These findings underscore the role of mixed metal exposure in amyloid-β dysregulation, tight junction disruption, and cerebellar dysfunction.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-026-42725-3.
Keywords: Amyloid-beta proteins, Oxidative stress markers, Low dose metal mixture, Cerebellar toxicity, Occludin
Subject terms: Biochemistry, Diseases, Drug discovery, Neurology, Neuroscience
Introduction
Human exposure to heavy metals is unfortunately inevitable due to constant and rapid urbanization and anthropogenic activities. Environmental contamination with heavy metals is posited as a possible factor in the development and progression of central nervous system related neurodegenerative disorders1,2 and compromised neurocognitive function, particularly in adults3. Heavy metal toxicity has severe and long-term consequences on the brain, resulting in cognitive impairment. There has been an upsurge of neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and prion’s disease in the recent past. It is currently reported that 5.3 million of US population is afflicted with AD with expected cases to reach 13.5 million by 20504. Human studies showed that exposure to heavy metals during pregnancy may be associated with anxiety symptoms in childbearing woman and neurodevelopmental disorders in infants5.
Due to a protracted period of oil exploration and an upsurge in artisanal crude oil refining in the south-south region of Nigeria, lead (Pb), mercury (Hg), aluminum (Al) and manganese (Mn) are prevalent in this environment. Pb and Al are toxic and accumulate in both children and adult with disruption of normal physiological processes in various organs including the brain6. Lead is neurotoxic and crosses the blood-brain barrier (BBB). Its chronic exposure reduces antioxidants, increases oxidative stress, causes inflammation, morphologic damage, neurodegeneration and cognitive impairment in the brain2,7. Al is a non-essential, neurotoxic metal implicated in the pathogenesis of neurodegenerative processes; mainly deposited in the hippocampus, cerebral cortex and cerebellum8. Al has proinflammatory and pro-apoptotic effects with the ability to up-regulate various cytokines. Al induced neuronal degeneration and death manifested as cognitive decline as observed in Morri’s water maze task9. Aluminium administration causes learning and memory deficits in rabbits and other experimental animals10. Mn is an essential metal, vital in proper human health maintenance and a cofactor in neurotransmitter synthesis and metabolism11. In the case of chronic exposure, Mn is found in the brain, particularly in the motor control centres12 and the hippocampus; can lead to toxic effects13. Mn causes neurodegenerative disorders in these regions, with symptoms that include memory impairment, cognitive slowing, and decreased learning capacity and mental flexibility14,15. Toxic and sub-toxic levels of Mn may affect important cell signalling pathways that regulates cell survival, differentiation, and apoptosis, which are critically implicated in many neurodegenerative diseases16–18.
Human exposure to heavy metals and their potential adverse effects on neurocognitive functions occur in both young and adult populations19. Cerebellum, hippocampus and prefrontal cortex are the parts of the brain critical for neurodevelopment prone to various heavy metal accumulation after crossing the blood brain barrier2,20. Cerebellum plays a critical role in motor coordination and balance, aligning with the rotarod findings21. Cerebellum is particularly susceptible to intoxication and heavy metal poisoning including Pb, Al and Mn because it is the preferential site for their toxicity22. Al is largely deposited in the cerebellum and cortex and, implicated in pathogenesis of neurodegenerative diseases8. The cerebellum is increasingly recognized as vulnerable to amyloid pathology and oxidative injury, particularly in metal-induced neurotoxicity. Neurocognitive functions such as memory, attention, executive function, language, and visuospatial abilities are important in perception, processing and response to the environment23. Heavy metal exposure can contribute to cognitive impairment through various mechanisms such as oxidative stress, inflammation, neurotransmitter disruption, disruption of blood–brain barrier, neuroinflammation, alteration of neurotrophic factors, impaired synaptic plasticity, accumulation in specific brain regions, epigenetic modifications and neurodegenerative pathways19.
The dysregulation of these factors can impair cognitive function24. Heavy metals disrupt the balance of antioxidants, increase harmful reactive oxygen species (ROS) and impair mitochondrial function, disturbing cellular redox homeostasis25. Memory impairment is reported to be related to altered brain oxidative stress status26 and different antioxidants reduced oxidative damage in Alzheimer’s disease. It is reported that agents used to induce dementia-like conditions in rodent models usually cause oxidative damage, inflammation, apoptosis and neurochemical alteration 27. A cascade of events ensues when excessive ROS is produced. Cellular damage stimulates inflammatory processes resulting in activation of transcription factors, synthesis and release of various inflammatory cytokines and mediators28. Oxidative stress from metal exposure compromises the activity of the ubiquitin proteasome system, resulting in protein aggregation which disrupts cellular processes resulting in cell death29. Nrf2 is a redox-sensitive transcription factor and closely related to many cell protection factors, which translocate to the nucleus to bind to antioxidant response element (ARE) under oxidative stress to induce expression of antioxidant genes, such as HO-1, NQO1 and GST30. Nrf-2 interferes with beta amyloid and p-tau pathways31. Cyclooxygenase-2 (COX-2), an isoform of the cyclooxygenase enzyme family, along with COX-1 and COX-3, are involved in the synthesis of prostanoids (eicosanoid sub-class) from an essential fatty acid- arachidonic acid. COX-2 is expressed constitutively at post-synaptic membranes by groups of neurons in the prefrontal cortex, hippocampus and amygdala while it is inducible in other cell types and by inflammatory cytokines (IL-1, IL-2, and TNF-α) in the brain32,33. COX-2 activity is important in neurogenesis and vital in tasks like synaptic plasticity, long-term potentiation, cognitive and behavioural functions34. COX-2, predominantly present in neurons is important in regulating brain functions such as synaptic plasticity35 though, its specific role in the hippocampus and cortex, which may be involved in cognitive functions, remains unclear36. However, over-expression of COX-2 is associated with neurotoxicity in acute conditions, such as hypoxia/ischemia and seizures, enhancing glutamate excitotoxicity and inflammatory chronic diseases such as neurodegenerative diseases34,35.
Humans’ exposure to heavy metals in the environment always occur as mixtures rather than singly and majority of them are neurotoxic37. Heavy metals may contribute to progression of neurodegenerative diseases and, interactions among the components of a metal mixture may result in synergistic toxicity38. Low level exposure to metals like Pb can disrupt normal central nervous system development and co-exposure to multiple metals can result in increased neurotoxicity compared to single metal exposures especially during early life39. Miller et al.,40 reported that the neurotoxicity of Hg at very low and otherwise safe levels is enhanced by co-exposure to Pb, Al, Mn, Cd, Zn, or Fe. Similarly, exposure to a nontoxic level of aluminium hydroxide markedly increased neuronal cell death when combined with Hg in an in vitro study41. Exposure to mixture of Al, Pb, Mn and Hg reduced the levels of antioxidants in the cerebral cortex and cerebellum, increased levels of MDA and NO; down-regulated cellular levels of Nrf242.
Accumulation of Pb, Al and Mn in the brain is implicated in the pathophysiology of neurodegenerative disorders10 and so the consideration that animals exposed to low dose mixture of these metals can be used as animal model for neurological study. The collective impact of exposure to a mixture of heavy metals on neurocognitive function has yet to be explored19,42 proposed that exposure to heavy metal mixture (Al, Pb, Mn and Hg) may promote the onset of Alzheimer disease as evinced by upregulated Caspase-3 levels, potentiated activity of acetylcholinesterase and decreased acetylcholine level with moderate histopathological alterations in cerebral cortex and cerebellum. Nevertheless, their study did not investigate the effect of low dose metal co-exposure on amyloidogenesis and neurotrophic factors in relation to oxidative damage in the brain. The effect of co-exposure to metals in the brain is imperative as the central nervous system is a common target organ for many environmentally toxic metals. Essential trace metals though necessary for normal cellular and enzyme activity, in their high levels together with other non-essential heavy metals and metalloids can damage biomolecules, impair cellular redox status, alter signal transduction, and cause protein misfolding, apoptosis, and malignant transformation43. Mn-Al-Mn are prevalent environmental contaminants in the Niger Delta due to oil exploration and artisanal refining activities. Pb and Al are well-established neurotoxic metals, while Mn is an essential metal with neurotoxic effects at elevated or chronic exposure levels. These metals share common transport pathways (e.g., transferrin/DMT1), enabling potential synergistic neurotoxicity. This study hypothesized that chronic low-dose exposure to a mixture of aluminium, manganese, and lead induces cerebellar toxicity through amyloid-β accumulation and occludin depletion, resulting in functional impairment. Therefore, this study investigates the possible outcome of low dose metal mixture on oxidative damage, expression of transcription factors, amyloidogenesis, inflammation and apoptosis in the cerebellum of male Wistar rats.
Materials and methods
Chemicals and reagents
Analytical pure grade compounds of Lead acetate (Pb (CH3COO)2), aluminum (III) chloride (AlCl3) and Manganese chloride (MnCl2.4H2O, ≥ 99.9%), were purchased from Sigma Chemical Co. (St. Louis, MO, USA); ELISA kits (Nrf-2, Catalog No. (E-EL-R1052), HO-1, Catalog No. (E-EL-R0488), BDNF Catalog No. (E-EL-R1235), COX − 2, Catalog No. (E-EL-R0792), Caspase-3 Catalog No. E-EL-R0160, Aβ1−40, Catalog No: E-EL-R3030, Aβ1−42 Catalog No: E-EL-R1402, Occludin Catalog No: (E-EL-H1073) were procured from Elabscience Biotechnology, Inc. Wuhan, China (Table S1).
Animals and ethics
Twenty – Five Young adult male Wistar rats (8–10 weeks old; 130–150 g) were used for this study and acclimatized for 2 weeks and housed at the Animal facility of the Department of Experimental Pharmacology and Toxicology, University of Port Harcourt, Rivers State. They were maintained at a 25 °C and humidity 55–60%, on a 12: 12 light dark cycle in well-ventilated standard polypropylene cages. The animals were allowed free access to animal feed and clean water ad libitum in adherence to the ARRIVE guidelines (Animal Research: Reporting In Vivo Experiments) checklist44. All experimental procedures were approved and performed according to the university committees’ guidelines for the use and care of animals. (UPH/CEREMAD/REC/MM188/003) in accordance with the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Science (NAS) and published by the National Institute of Health.
Animal welfare was monitored daily throughout the experimental period by trained personnel. Monitoring criteria included body weight changes, grooming behaviour, posture, locomotor activity, feeding and drinking patterns, and signs of distress (e.g., piloerection, lethargy, laboured breathing). Humane endpoints were predefined and included ≥ 20% body weight loss, severe lethargy, persistent anorexia, or any signs of severe pain or distress unresponsive to supportive care, at which point animals would be humanely euthanized. No invasive surgical or painful procedures were performed during the study. Animals were monitored daily for signs of discomfort or distress, and humane endpoints were predefined as described above. Routine analgesia was not required due to the non-invasive nature of the procedures; therefore, routine analgesia was not required.
Experiment
Animals were randomly assigned into experimental groups (n = 5 per group). Sample size was determined based on previous laboratory studies and published neurotoxicology literature demonstrating sufficient statistical power for biochemical and behavioral endpoints45, while adhering to the principles of Replacement, Reduction, and Refinement (3Rs)46. Rats received aluminum, manganese, lead, or their mixture orally at environmentally relevant low doses for 90 consecutive days. The 90-day exposure duration was selected to model sub-chronic to chronic environmental exposure consistent with OECD toxicological frameworks and cumulative neurotoxicity, amyloidogenesis, and oxidative stress following prolonged low-dose exposure as shown on Table 1:
Table 1.
Experimental design.
| Experimental groups | Treatment |
|---|---|
| Group 1 (Control) | Drinking water alone |
| Group 2 | Heavy metal mixtures (Pb 20 mg/kg, Al 35 mg/kg and Mn 0.564 mg/kg body weight) |
| Group 3 | Pb 20 mg/kg body weight alone |
| Group 4 | Al 35 mg/kg body weight alone |
| Group 5 | Mn 0.564 mg/kg body weight alone |
The following environmental relevant doses of Pb 20 mg/kg, Al 35 mg/kg and Mn 0.564 mg/kg body weight were chosen based on the previous reports of Yang et al., and30 for Pb,47,48 for Al and49–51 for Mn, respectively. HMM were prepared separately as individual salt solutions in deionized water; one gram each of Pb (CH3COO)2), AlCl3 and MnCl2.4H2O were separately dissolved in 100 ml deionized water in a 150 ml capacity airtight conical flask, stored in the refrigerator until needed. After 90 days of treatments, the rats were sacrificed under IP pentobarbitone (50 mg/kg) anaesthesia, sacrificed and the cerebellar tissue collected immediately for further experiments.
Metal concentrations in cerebellum
Cerebellum were weighed individually, frozen and freeze-dried for 24 h using Lyovac lyophilizer GT2e (Steris, Germany). The samples were weighed after drying, put into the polytetrafluoroethylene digestion tube and 65% nitric acid (Merck, Germany) was added to each sample to obtain a dilution factor (DF) of 10 (2.0–6.0 ml of nitric acid and 0.2–0.6 g of sample). Prepared samples were kept overnight to slow mineralization, and the samples were subsequently mineralized in a microwave oven (Mars Xpress 5, CEM USA). Concentrations of Pb, Al and Mn in the mineralized samples were determined using Atomic Absorption Spectrometer (AAS) 7000 (Shimadzu, Japan). Graphite furnace atomization (GF-AAS) was used for Pb and Al while flame atomization (F-AAS) was used for Mn and, analyses were done in triplicates according to52. The percentage RSD for GF-AAS and F-AAS analysis did not exceed 5 and 7% respectively. Atomic absorption spectrometry (AAS) was used to determine the concentrations of the metals Pb, Al, and Mn that bioaccumulated in the cerebellum after treatment.
Rotarod test
The animals were trained to walk on the accelerating rotarod (UgoBasile 47600, Milan, Italy) as previously described in our lab53. The rotarod consisted of a cylinder with a diameter of 3 cm on which five animals could run at the same time, set apart by panels of adequate size ensuring they don’t see themselves. The speed of the rod was increased from 4 rpm to 40 rpm for 300 s. Thereafter the animals were placed back in their cages. As soon as the animal could not maintain its balance, it fell off the device and the time was recorded. In the first week of the experiment, the animals were trained to get used to the device and baseline values were recorded. Rotarod testing was conducted at baseline and subsequently at predefined weekly intervals. Daily training was limited to the acclimatization phase to avoid learning bias54,55.
Biochemical analysis
The antioxidant enzyme activity of Superoxide dismutase (SOD) was assayed using the method by Misra and Fridovich56 based on the principle that SOD has the capacity to inhibit the autoxidation of epinephrine at pH 10.2. Catalase (CAT) activity was determined using a slight modification of the Clairborne57 technique. It is premised on the principle that catalase in the tissue will split hydrogen peroxide estimated at 240 nm using a spectrophotometer. Glutathione peroxidase (GPx) activity was determined using the method of Rotruck et al.58 while the technique by Jollow et al.59 was adopted for the evaluation of Reduced glutathione (GSH) activity.
The level of oxidative stress marker (malondialdehyde -MDA) was assayed using method of Ohkawa and Ohishi60. This method is based on the principle that in acidic medium, MDA reacts with the chromogenic reagent, 2-thiobarbituric acid (TBA) with the formation of a pink coloured complex at 532 nm absorbance.
Immunosorbent assays in the Cerebellum
The transcription factors (Nrf-2, HO-1, BDNF), inflammation markers (COX − 2, caspase-3) amyloid precursor proteins (Aβ1−40, Aβ1−42) and occludin were evaluated using Enzymes linked immunosorbent assay (ELISA) kits. Triplicates of the assay was done with NM 9602 Microplate Reader according to the manufacturer’s instructions (Elab Science Biotechnology Company, (Beijing, China). The concentrations of biomarkers in the rats’ cerebellum were calculated by comparing the optic density of the samples to the standard curve. The ELISA calibration curves consisted of six non-zero standard concentrations covering the assay’s dynamic range; back-calculated concentrations met acceptance criteria (± 15% nominal, ± 20% at LLOQ) consistent with FDA/ICH bioanalytical guidelines. Duplicate wells (i.e., Intra-plate precision yielded CVs < 10%, and inter-assay CVs across three independent runs remained < 15%. Recovery was evaluated by spiking matrix-matched samples at low/mid/high levels, achieving 70–130% recovery. Each assay run incorporated QC samples and utilized Levey-Jennings plots with Westgard rules to ensure consistency; any runs failing QC were excluded. All validation and assay records were maintained per regulatory standards.
Statistical analysis
Data obtained were expressed as mean ± standard deviation (SD) and data were analysed with GraphPad® Version 5 using one-way analysis of variance (ANOVA) followed by Bonferroni’s post-hoc test. Values were considered significant at p < 0.05.
Result
Bioaccumulation of Pb, Al and Mn (mg/kg) in the cerebellum
The bioaccumulation of Pb, Al and Mn in rat cerebellum after exposure to Pb, Al, Mn as individual metals and Pb-Al-Mn mixture is shown in Table 2. There was no significant difference in the bioaccumulation (0.37 ± 0.051 mg/kg) of Pb after exposure to Pb (20 mg /kg) as an individual metal and when it was administered as a mixture, (Pb (20 mg /kg), Al (35 mg / kg) Mn (0.56 mg/ kg)). There were, however, significant differences in the bioaccumulation of Al and Mn after exposure as individual metals and when it was given as a mixture. Al bioaccumulation was higher and Mn was lower in the metal mixture (Pb (20 mg /kg), Al (35 mg / kg) Mn (0.56 mg/ kg)) group.
Table 2.
Bioaccumulation of Pb, Al and Mn (mg/kg) in the cerebellum of rats after exposure to Pb, Al, Mn and Pb-Al-Mn tertiary mixture.
| Group. | Pb | Al | Mn |
|---|---|---|---|
| Control De-ionized water | - | - | - |
| Pb (20 mg /kg) | 0.37 ± 0.051 | - | . |
| Al (35 mg / kg) | - | 0.26 ± 0.06* | - |
| Mn (0.56 mg/ kg) | - | - | 0.50 ± 0.09* |
| Metal mixture | 0.38 ± 0.021 | 0.9 ± 0.05 | 0.17 ± 0.05 |
| (Pb, Al and Mn) |
Data are expressed as mean ± SD. (n = 5). One-way ANOVA was used to test for significant, followed by post hoc test for multiple comparisons of means: DF (4; 5), F = 4.583. *p-value = 0.01or p < 0.05 was considered statistically significant.
Effect of Pb, Al and Mn as individual metals Vs Pb, Al, Mn and Pb-Al-Mn tertiary mixture on rota-rod performance test
Pb, Al and Mn whether as individual metals or as tertiary mixture significantly reduced rotarod performance test of the animals compared to the control as shown on Fig. 1. There was no significant between of the test animal rotarod performance for the individual metals when compared with the HMM.
Fig. 1.
Time (sec) the animals spent on the rotating rod after the administration of lead (Pb), aluminum (Al), manganese (Mn) and tertiary metal (loid) mixture on a rotarod apparatus Values are expressed as means ± SD. *p-value = 0.01or p < 0.05 was considered statistically significant.
Effect of heavy metals on antioxidant and lipid peroxidation in the cerebellum
Figure 2 depicts the effect of HMM alone and individual metals (i.e., Pb, Al and Mn) on the antioxidant enzymes activities (GPx, CAT, and SOD) as well as GSH level in the cerebellar cortex of rats. The exposure to HMM and individual metal alone caused significant decrease in GPx, CAT and SOD activities and GSH level in the cerebellar cortex of the treated rats when compared to the control. Moreover, exposure to HMM also resulted in significant decrease in GPx and CAT when compared to Pb, Al, and Mn alone. Furthermore, Fig. 2 depicts the effects of HMM alone and individual metals (i.e., Pb, Al and Mn) on oxidative stress marker (LPO) in the cerebellar cortex of rats. Exposure of rats to MM alone caused a significant increase in LPO level in the cerebellar cortex of rats when compared to the control.
Fig. 2.
Effect of heavy metals on antioxidants and oxidative stress marker in the cerebellum. a Significantly different compared to control; b significantly different compared to HMM; c significantly different compared to Pb. *p-value = 0.01or p < 0.05 was considered statistically significant.
Effect of Heavy metals on transcription factors Nrf-2, HO-1 and BDNF in the cerebellum
Figure 3 depicts the effect of HMM alone and individual metals (i.e., Pb, Al and Mn) on Nrf-2, HO-1 and BDNF levels in the cerebellar cortex of rats. The exposure to HMM and individual metal alone caused significant (p < 0.05) increase in Nrf-2 and BDNF levels and significant (p < 0.05) decrease in HO-1 level in the cerebellar cortex of the treated rats when compared to the control. The neurotrophic factor BDNF was significantly reduced in the Pb, and Al only treated groups compared to the control (Fig. 3). HMOX-1 was significantly down regulated in metal mixture, Pb and Mn only treated groups compared to control. The neurotrophic factor BDNF was significantly reduced in the Pb and Al only treated groups compared to the control (Fig. 3).
Fig. 3.
Effect of Heavy metals on transcription factors Nrf-2, HMOX-1 and BDNF in the cerebellum. a Significantly different compared to control; c significantly different compared to Pb. *p-value = 0.01or, p < 0.05 was considered statistically significant.
Effect of heavy metals on COX-2 and Caspase-3 in the cerebellum
Figure 4 depicts the effect of HMM alone and individual metals (i.e., Pb, Al and Mn) on neuroinflammation marker (COX-2) and apoptotic marker (caspase-3) in the cerebellar cortex of rats. The exposure to HMM and individual metal alone caused significant (p < 0.05) increase in COX-2 and Caspase levels in the cerebellar cortex of the treated rats when compared to the control.
Fig. 4.
Effect of Heavy metals on COX 2 and Caspase-3 in the cerebellum. a Significantly different compared to control; b significantly different compared to HMM *p-value = 0.01or or p < 0.05 was considered statistically significant.
Effect of heavy metals on amyloid precursor proteins in the cerebellum
Figure 5 depict the effect of HMM alone and individual metals (i.e., Pb, Al and Mn) on amyloid precursor proteins (Aβ-40 and Aβ-42) in the cerebellar cortex of rats. The protein expression of Aβ-40 and Aβ-42 were significantly (p ≤ 0.05) upregulated in the rats cerebellar following exposure to HMM and individual metals alone when compared with the control. There was a significant (p < 0.01) increase in Aβ1−40 and Aβ1−42 formation in the metal mixture and single metal treated groups compared to the control (Fig. 5).
Fig. 5.
Effect of Heavy metals on amyloid precursor proteins in the cerebellum. a Significantly different compared to control; b significantly different compared to HMM; c significantly different compared to Pb; d significantly different compared to Al* p-value = 0.01or or p < 0.05 was considered statistically significant.
Effect of heavy metals on occludin in the cerebellum
Figure 6 depict the effect of HMM alone and individual metals (i.e., Pb, Al and Mn) on occludin in the cerebellar cortex of rats. Exposure to the heavy metal mixture resulted in a significant (p < 0.001) reduction in occludin levels in the cerebellar cortex compared to the control and single-metal treated groups (Fig. 6).
Fig. 6.
Effect of heavy metals on occludin proteins in the cerebellum. a Significantly different compared to control. *p-value=0.05.was considered statistically significant. There was a significant (p < 0.001) reduction in occludin level in the metal mixture treated group compared to the control and single metal only treated groups (Fig. 6).
Effect of heavy metals on cerebellar architecture
Photomicrograph (X400) of toluidine blue stained section of the cerebellar tissue after the administration of de-ionized water, showing a normal cerebellum with no structural changes in the Pia mater (PM), gray matter (GM), Outer molecular layer (ML) inner granular layers (GL) and white matter (WM). The cerebellum is the area of the hindbrain that controls motor movement coordination, balance, and equilibrium and muscle tone. Panel 2. Photomicrograph (X 400) of Toluidine blue-stained cerebellar tissue section of the (Pb + Al+Mn) treated group, showing severe neuronal loss with the Purkinje and granule layers appearing thinner and vacuolated. There are pyknotic granular cells undergoing necrosis (arrow), with dense dark blue plaques. Panel 3: Photomicrograph (X400) after treatment with Pb only, showed disruption of normal architecture of the cerebellar tissue and moderate neuronal loss. There are pyknotic granular cells undergoing necrosis (arrows) with dense, dark blue plaques. Panel 4: Al only treated group photomicrograph (X400) of the cerebellar tissue section. Showed disruption of the cerebellar layer with focal areas mild neuronal loss. There is neuronal degeneration with pyknotic neuronal nuclei and irregular arrangement of Purkinje cells. Panel 5: Mn only treated group photomicrograph (X400). Showed mild neuronal loss.
Discussion
Heavy metals are present as mixtures in the environment where humans are routinely exposed to these mixtures. Therefore, in this work, we studied the possible mechanism of induced neurotoxicity of low dose metal mixtures (Pb, Al and Mn) in the cerebellum using a rat model. Concurrent cerebellar accumulation of Al and depletion of Mn as shown in this study disrupts metal homeostasis via shared transport systems, for example both Al and Mn utilize shared the transferrin/transferrin receptor (Tf–TfR) and divalent metal transporter 1 (DMT1) pathways to cross the blood–brain barrier61,62. Also, Al–Tf complexes can down‑regulate TfR and reduce Mn uptake, therefore, compromises antioxidant and mitochondrial resilience, and perturbs neurotransmitter regulation63. This synergistic dysregulation exacerbates neuronal vulnerability and may contribute to the pathogenesis of neurodegenerative disorders64.
The formation of ROS is a common phenomenon in normal cellular metabolism though, tightly regulated by the cellular antioxidant system. Oxidative stress occurs due to an imbalance between antioxidant defense and free radicals (ROS and RNS) in favour of the overproduction of free radicals. Redox homeostasis is maintained by both enzymatic and non-enzymatic antioxidants. This study showed that low dose heavy metal mixture affected the redox homeostasis in the cerebellum as seen by depletion of antioxidants SOD, CAT and GSH activities. Malondialdehyde was significantly elevated in the metal mixture exposed groups compared to the control group. Other studies also observed that low dose metal mixtures (Pb, He, Al and Mn) and (Pb, Cd and Hg) reduced antioxidants levels and increased lipid peroxidation in the brain of rats42,65. The decreased antioxidant enzymes may be the result of heavy metal affinity for sulfhydryl groups restricting its ability to scavenge ROS (Virgolin and Aschner, 2021). The decreased levels of peroxisomal enzyme catalase (CAT) may have affected H2O2 removal that increased lipid peroxidation, which can lead to neuronal cell death. GSH is the main non-enzymatic antioxidant that catalyses H2O2 reduction66. SOD is a major antioxidant enzyme that could remove ROS, protects cells from the oxidative damage of many biological macromolecules67. So, the decreased SOD activity observed in this study would increase free radicals, which in turn cause the production of toxic factors/oxidative stress, further confirmed by the reduced GSH levels in cerebellum of metal mixture exposed rats.
Environmental heavy metals can bioaccumulate in the general population and cause various neurobehavioral deficits68,69. Chronic individual heavy metal exposure has been reported to impair motor coordination using a rota-rod test in male rats70,71. Although there is a plethora of reports on behavioral effects after single heavy metal exposure; there is sparsity of data heavy metal mixture exposure. One study reported that a mixture of heavy metals induced synergistic neurotoxicity, leading to impairments in neurobehavioral functions72. The present study suggests that the exposure to heavy metal mixture can collectively cause the impairment of motor function. Mixed exposure to metals may affect the processes of absorption, distribution, metabolism, and excretion of each metal, leading to metal–metal interactions, such as competition, antagonism, and synergism68,73.
The cerebellum coordinates movement via control of diverse muscular systems to ensure fluency, synchrony and precision of different muscles. In a synchronous precision, the cerebellum acquires ceaseless feedback information about all forms of movements whether intended or actual. Cerebellar atrophy is often accompanied by different forms of ataxia and an unbalanced and tottering gait74. In the present study, heavy metal either singly or as cocktail mixture -exposed rats exhibited significant motor deficits. This observation is like previous reports by Bazrgar and co-workers75. It has previously been shown that low dose heavy exposure in rats impacts on the body burden of heavy metals75,76 as seen in the present study with significant higher cerebellar concentrations of Pb, Al and Mn than control unexposed rats. The bioaccumulated heavy metals is thought to be retained for a long time even after exposure given the long half lives of these heavy metals. Consequently, the spatial and temporal patterns of the cerebellar heavy metal bioaccumulation precipitate neurobehavioral abnormalities associated with toxic heavy metal exposure.
Pb and Al have been shown to decrease GSH as the result of the inhibition of thiols groups, reducing the antioxidant enzymes activities, substituting Ca2+, Fe2+, or Zn2+ or altering the integrity, permeability and functionality of membranes, favouring lipid peroxidation77. The marked increased level of malondialdehyde (MDA) in the metal mixture group compared to single metal exposure could possibly be due to additive toxicity of the heavy metals. The decreased antioxidant levels in the cerebrum increased the level of ROS production that could possibly lead to mitochondrial damage of neurons in the cerebrum. During oxidative stress, neurons undergo dendritic alterations characterized by dendritic contraction, which results in perturbations in neuronal connectivity78. Oxidative stress also adversely affects other cellular components of the CNS like astrocytes, microglia and oligodendrocytes; their perturbations are implicated in a few neurological disorders. Nrf2 is a redox-sensitive transcription factor and closely related to many cell protection factors, which translocate to the nucleus to bind to antioxidant response element (ARE) under oxidative stress to induce expression of antioxidant genes, such as HO-1, NQO1 and GST28,30. It was observed that their Nrf2 in metal mixture rats did not significantly differ from the control. However, the antioxidant gene, HO-1 expression was decreased in the metal mixture compared to control. HO-1 plays an important role in preventing ROS formation and oxidative injury by maintaining cellular redox homeostasis27. Hmox-1 is a stress-induced enzyme, which exerts cytoprotective effect against inflammatory responses through inhibiting inflammation mediators79,80. The increased level of MDA observed in this study contributed to oxidative injury and the down-regulated HO-1 expression implies that the neurons were HO-1 suppression despite unchanged Nrf-2 likely involves transcriptional repression (e.g., Bach1, NF-κB) or post-transcriptional mechanisms, decoupling it from Nrf-2’s status81. The reduced levels of occludin, in the cerebellum seem to be linked to synergistic oxido-inflammatory pathways activated by mixed metal exposure45.
Oxidative stress is a common cause of neuronal cell loss in various neurodegenerative disorders and considered an important player in the pathophysiology of Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Huntington’s disease82. Oxidative stress leads to perturbation of many cellular functions which is highly detrimental to neuronal survival, contributing to the aetiology of neurodegenerative diseases83.
Brain-derived neurotrophic factor (BDNF) is a major player in neuroplasticity, neurogenesis, and neuroprotection in the brain84 and have been reported to be beneficial in the recovery and the prevention of neurodegenerative motor disorders like Parkinson’s disease, and Huntington’s disease85. BDNF is crucial motor recovery after ischemic stroke and brain injury since the recovery of motor function is known to accompanied by an increase in BDNF expression86, whereas downregulation of BDNF attenuates the recovery87. The significantly reduced BDNF in the heavy metal treated rats especially Pb and Al only treated groups in comparison to the control may at least explain in part the significantly diminished rotarod performance test in the present study. As a survival factor BDNF has been shown to regulate morphologic development and maturation of cerebellar granule and Purkinje cells88 and its administration counters some forms of cerebellar degeneration and sensorimotor deficits89.
Accumulation of ROS and RNS is also involved in the accumulation of toxic protein aggregates that typify some neurodegenerative disorders82. This study demonstrated that although COX-2 and caspase-3 levels were significantly increased alongside increased oxidative stress and amyloid-β (Aβ) accumulation. These findings suggest that oxidative stress, inflammation, and apoptotic signalling are involved in the observed cerebellar injury driving the observed effects.
The significant increase in caspase-3 levels observed in the heavy metal mixture and single metal groups suggests activation of apoptotic signalling pathways in the cerebellum. However, it is important to note that this study quantified total caspase-3 protein levels using ELISA and did not assess cleaved (active) caspase-3 or enzymatic activity. Therefore, while the elevation in caspase-3 is indicative of pro-apoptotic signalling, definitive conclusions regarding caspase-dependent apoptosis cannot be made. Future studies incorporating cleaved caspase-3 detection or activity assays would further clarify the specific apoptotic mechanisms involved. Oxidative stress, secondary to Aβ accumulation are known to trigger cellular damage and inflammation90. Usually COX-2 is upregulated in response to oxidative stress and Aβ increases which tend to exacerbate the inflammatory response. In some cases, upregulation of COX-2 may not necessarily correlate with Aβ increases, thus suggesting a complex and multifaceted relationship91. More studies are required to elucidate these intricate mechanisms.
This study showed elevated amyloid-β peptides (Aβ) proteins in the rats treated with low dose metal mixture. Aβ peptides influence the expression and localization of TJ proteins such as claudin 5, occludin and ZO-1, and lead to disruption of tight junctions and loss of integrity of blood-brain-barrier92. Aβ is toxic to endothelial cells in the human brain via binding to the receptor for advanced glycation end-products (RAGE) and induction of ROS production, which ultimately leads to disruption of tight junctions and loss of BBB integrity92. The Aβ1−42 peptide accumulation around brain micro vessels was found to increased blood brain barrier permeability, disrupted claudin 5, ZO-1 and occludin92. Amyloid oligomers are the most toxic species that cause neurodegenerative diseases4. The accumulation of toxic protein aggregates is one of the processes that activate cell death pathways via apoptosis, necrosis, ferroptosis or autophagy93. Occludin is an integral tight junction protein that forms part of epithelial and endothelial junctional complexes that regulate barrier properties94. Occludin protein was downregulated in the cerebellum cortex after exposure of rats to low dose metal mixture in this work. The implication is that there will be increased permeability of the toxic metals through the blood brain barrier into the cerebellum with attendant neurodegeneration. The cerebellum cortex contained amyloid plaques in the molecular and granular layers. The presence of amyloid plaques, gliosis and neuronal degeneration followed by disorganization in the normal architecture of the cerebellar layer are indicative of cerebellar pathology. The limited behavioural data in the present study is considered a limitation which will be addressed in future studies.
Conclusion
This study demonstrates that chronic co-exposure to low doses of Pb, Al, and Mn produces additive neurotoxic effects in the cerebellum of adult male Wistar rats. Mixed-metal exposure suppressed antioxidant defenses, increased lipid peroxidation, elevated amyloid-β levels, upregulated COX-2 and caspase-3, and reduced occludin expression, suggesting oxidative stress-mediated cerebellar dysfunction and potential blood–brain barrier compromise. These findings support the concept that environmentally relevant metal mixtures may exert greater neurotoxic risk than single-metal exposures.
Supplementary Information
Below is the link to the electronic supplementary material.
Author contributions
BDD, CNO, ANE,: formal analysis and investigation; OEO, TCU, KWN, CNOb,: writing—original draft preparation, writing—review and editing, visualisation; CNO, OEO: conceptualisation, data curation, supervision, writing—review and editing. All the authors have read and approved the manuscript.
Data availability
All the data generated or analysed during this studyare included in this published article.
Declarations
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Chinna N. Orish, Email: chinna.orish@uniport.edu.ng
Orish Ebere Orisakwe, Email: orishebere@gmail.com.
References
- 1.Al Olayan, E. M., Aloufi, A. S., AlAmri, O. D., Ola, H. & Moneim, A. E. A. Protocatechuic acid mitigates cadmium-induced neurotoxicity in rats: Role of oxidative stress, inflammation and apoptosis. Sci. Total Environ.723, 137969 (2020). [DOI] [PubMed] [Google Scholar]
- 2.Balali-Mood, M., Naseri, K., Tahergorabi, Z., Khazdair, M. R. & Sadeghi, M. Toxic mechanisms of five heavy metals: mercury, lead, chromium, cadmium, and arsenic. Front. Pharmacol.12, 643972 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Weider, S. et al. Neurocognitive function and associations with mental health in adults born preterm with very low birthweight or small for gestational age at term. Front. Psychol.13, 1078232 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Salahuddin, P. et al. The role of amyloids in Alzheimer’s and Parkinson’s diseases. Int. J. Biol. Macromol.190, 44–55 (2021). [DOI] [PubMed] [Google Scholar]
- 5.de Water, E. et al. Prenatal metal mixture concentrations and reward motivation in children. Neurotoxicology88, 124–133 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Collin, M. S. et al. Bioaccumulation of lead (Pb) and its effects on human: A review. J. Hazard. Mater. Adv.7, 100094 (2022). [Google Scholar]
- 7.Renu, K. et al. Molecular mechanism of heavy metals (Lead, Chromium, Arsenic, Mercury, Nickel and Cadmium)-induced hepatotoxicity–A review. Chemosphere271, 129735 (2021). [DOI] [PubMed] [Google Scholar]
- 8.Bryliński, Ł. et al. Aluminium in the human brain: routes of penetration, toxicity, and resulting complications. Int. J. Mol. Sci.24 (8), 7228 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Al-Amin, M. M. et al. Astaxanthin ameliorates aluminum chloride-induced spatial memory impairment and neuronal oxidative stress in mice. Eur. J. Pharmacol.777, 60–69 (2016). [DOI] [PubMed] [Google Scholar]
- 10.Chacko, A. & Ittiyavirah, S. P. Neuroprotective effect of against aluminium-induced Gracilaria corticata neurotoxicity in the hippocampus and cerebral cortex of rat brain: Biochemical and histological approach. Asian J. Pharm. Pharmacol.5 (3), 604–613 (2019). [Google Scholar]
- 11.Golub, M. S. et al. Neurobehavioral evaluation of rhesus monkey infants fed cow’s milk formula, soy formula, or soy formula with added manganese. Neurotoxicol. Teratol.27 (4), 615–627 (2005). [DOI] [PubMed] [Google Scholar]
- 12.Dobson, A. W., Erikson, K. M. & Aschner, M. Manganese neurotoxicity. Ann. N. Y. Acad. Sci.1012 (1), 115–128 (2004). [DOI] [PubMed] [Google Scholar]
- 13.Miah, M. R. et al. The effects of manganese overexposure on brain health. Neurochem. Int.135, 104688 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Josephs, K. A. et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology64 (12), 2033–2039 (2005). [DOI] [PubMed] [Google Scholar]
- 15.Meyer-Baron, M., Knapp, G., Schäper, M. & van Thriel, C. Performance alterations associated with occupational exposure to manganese—a meta-analysis. Neurotoxicology30 (4), 487–496 (2009). [DOI] [PubMed] [Google Scholar]
- 16.Bryan, M. R. & Bowman, A. B. Manganese and the insulin-IGF signaling network in Huntington’s disease and other neurodegenerative disorders. Neurotoxic. Metals, 113–142. (2017). [DOI] [PMC free article] [PubMed]
- 17.Ling, J., Yang, S., Huang, Y., Wei, D. & Cheng, W. Identifying key genes, pathways and screening therapeutic agents for manganese-induced Alzheimer disease using bioinformatics analysis. Medicine, 97 (22), e10775. (2018). [DOI] [PMC free article] [PubMed]
- 18.Roth, J. A. Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese. Neurotoxicology44, 314–325 (2014). [DOI] [PubMed] [Google Scholar]
- 19.Althomali, R. H. et al. Exposure to heavy metals and neurocognitive function in adults: a systematic review. Environ. Sci. Europe. 36 (1), 18 (2024). [Google Scholar]
- 20.de Andrade, V. L., Santos, D. & Aschner, M. A. P. M., Neurotoxicity of metal mixtures. In Advances in neurotoxicology (Vol. 5, 329–364). Academic. (2021). [DOI] [PMC free article] [PubMed]
- 21.van der Heijden, M. E. Converging and diverging cerebellar pathways for motor and social behaviors in mice. Cerebellum23 (5), 1754–1767 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Manto, M. Toxic agents causing cerebellar ataxias. Handb. Clin. Neurol.103, 201–213 (2012). [DOI] [PubMed] [Google Scholar]
- 23.Harvey, P. D. Domains of cognition and their assessment. Dialog. Clin. Neurosci.21 (3), 227–237 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bathina, S. & Das, U. N. Brain-derived neurotrophic factor and its clinical implications. Arch. Med. Sci.11 (6), 1164–1178 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Koyama, H., Kamogashira, T. & Yamasoba, T. Heavy metal exposure: molecular pathways, clinical implications, and protective strategies. Antioxidants13 (1), 76 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.El-Khadragy, M., Al-Olayan, M., Abdel Moneim, E. & E., &, A Neuroprotective effects of Citrus reticulata in scopolamine-induced dementia oxidative stress in rats. CNS Neurol. Disorders-Drug Targets (Formerly Curr. Drug Targets-CNS Neurol. Disorders). 13 (4), 684–690 (2014). [DOI] [PubMed] [Google Scholar]
- 27.Al-Quraishy, S. et al. Myristica fragrans seed extract reverses scopolamine-induced cortical injury via stimulation of HO-1 expression in male rats. Environ. Sci. Pollut. Res.27 (11), 12395–12404 (2020). [DOI] [PubMed] [Google Scholar]
- 28.AL-Megrin, W. A. et al. Luteolin protects against testicular injury induced by lead acetate by activating the Nrf2/HO‐1 pathway. IUBMB life. 72 (8), 1787–1798 (2020). [DOI] [PubMed] [Google Scholar]
- 29.Çubukçu, H. C. et al. Oxidative and nitrosative stress in serum of patients with Parkinson’s disease. Neurol. Sci.37, 1793–1798 (2016). [DOI] [PubMed] [Google Scholar]
- 30.Liu, C. M. et al. Effects of gastrodin against lead-induced brain injury in mice associated with the Wnt/Nrf2 pathway. Nutrients12 (6), 1805 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Osama, A., Zhang, J., Yao, J., Yao, X. & Fang, J. Nrf2: a dark horse in Alzheimer’s disease treatment. Ageing Res. Rev.64, 101206 (2020). [DOI] [PubMed] [Google Scholar]
- 32.Hoozemans, J. J. M., Rozemuller, J. M., Van Haastert, E. S., Veerhuis, R. & Eikelenboom, P. Cyclooxygenase-1 and-2 in the different stages of Alzheimer’s disease pathology. Curr. Pharm. Design. 14 (14), 1419–1427 (2008). [DOI] [PubMed] [Google Scholar]
- 33.Westwell-Roper, C. & Stewart, S. E. Commentary: neurobiology and therapeutic potential of cyclooxygenase-2 (COX-2) inhibitors for inflammation in neuropsychiatric disorders. Front. Psychiatry. 11, 264 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Minghetti, L. Role of COX-2 in inflammatory and degenerative brain diseases. Inflamma. Pathogenesis Chronic Dis.: COX-2 Controversy, 127–141. (2007). [DOI] [PubMed]
- 35.Yang, H. & Chen, C. Cyclooxygenase-2 in synaptic signalling. Curr. Pharm. Design. 14 (14), 1443–1451 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Syed, H., Ikram, M. F., Yaqinuddin, A. & Ahmed, T. Cyclooxygenase I and II inhibitors distinctly enhance hippocampal-and cortex-dependent cognitive functions in mice. Mol. Med. Rep.12 (5), 7649–7656 (2015). [DOI] [PubMed] [Google Scholar]
- 37.Fairbrother, A., Wenstel, R., Sappington, K. & Wood, W. Framework for metals risk assessment. Ecotoxicol. Environ. Saf.68 (2), 145–227 (2007). [DOI] [PubMed] [Google Scholar]
- 38.Pyatha, S., Kim, H., Lee, D. & Kim, K. Association between heavy metal exposure and Parkinson’s disease: a review of the mechanisms related to oxidative stress. Antioxidants11 (12), 2467 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sanders, A. P., Henn, C., Wright, R. O. & B., & Perinatal and childhood exposure to cadmium, manganese, and metal mixtures and effects on cognition and behavior: a review of recent literature. Curr. Environ. health Rep.2, 284–294 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Miller, K., Ochudło, S., Opala, G., Smolicha, W. & Siuda, J. Parkinsonism in chronic occupational metallic mercury intoxication. Neurol. Neurochir. Pol.37, 31–38 (2003). [PubMed] [Google Scholar]
- 41.Haley, B. E. Mercury toxicity: genetic susceptibility and synergistic effects. Med. Veritas. 2 (2), 535–542 (2005). [Google Scholar]
- 42.Dike, C. et al. Selenium and zinc alleviate quaternary metal mixture-induced neurotoxicity in rats by inhibiting oxidative damage and modulating the expressions of NF-kB and Nrf2/Hmox-1 pathway. IBRO Neurosci. Rep.15, 57–67 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Haidar, Z., Fatema, K., Shoily, S. S. & Sajib, A. A. Disease-associated metabolic pathways affected by heavy metals and metalloid. Toxicol. Rep.10, 554–570 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. J. Cereb. Blood Flow. Metabolism. 40 (9), 1769–1777 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Dooka, B. D. et al. Rice bran extract ameliorate heavy metal mixture induced hippocampal toxicity via inhibiting oxido-inflammatory damages and modulating Hmox-1/BDNF/Occludin/Aβ40/Aβ42 in rats. Toxicol. Res.14 (2), 049 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ferrara, F. et al. Culture of care in animal research–Expanding the 3Rs to include people. Lab. Anim.56 (6), 511–518 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Afolabi, O. B. et al. Nephroprotective Effects of Caffeine, Vanillin, and Their Combination against Experimental AlCl3-Induced Renal Toxicity in Adult Male Wistar Rats. Biochem. Res. Int.2023 (1), 6615863 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Mesole, S. B., Alfred, O. O., Yusuf, U. A., Lukubi, L. & Ndhlovu, D. Apoptotic inducement of neuronal cells by aluminium chloride and the neuroprotective effect of eugenol in Wistar rats. Oxidative Med. Cell. Longev.2020 (1), 8425643 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Andrade, V. M., Aschner, M. & Santos, M. D. A. P. Neurotoxicity of metal mixtures. Neurotoxicity Metals, 227–265. (2017). [DOI] [PubMed]
- 50.Martinez-Finley, E. J., Gavin, C. E., Aschner, M. & Gunter, T. E. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic. Biol. Med.62, 65–75 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Peres, T. V. et al. Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies. BMC Pharmacol. Toxicol.17 (1), .57. (2016). [DOI] [PMC free article] [PubMed]
- 52.Kubaszewski, Ł. et al. Comparison of trace element concentration in bone and intervertebral disc tissue by atomic absorption spectrometry techniques. J. Orthop. Surg, Res.9, 1–8 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Orisakwe, O. E. et al. Prosopis africana exerts neuroprotective activity against quaternary metal mixture-induced memory impairment mediated by oxido-inflammatory response via Nrf2 pathway. AIMS neuroscience, 11 (2), p.118. (2024). [DOI] [PMC free article] [PubMed]
- 54.Pritchett, K. & Mulder, G. B. The rotarod. J. Am. Assoc. Lab. Anim.42, 49–49 (2003). [PubMed] [Google Scholar]
- 55.van den Berg, R. et al. Rotarod motor performance and advanced spinal cord lesion image analysis refine assessment of neurodegeneration in experimental autoimmune encephalomyelitis. J. Neurosci. Meth. 262, 66–76. 10.1016/j.jneumeth.2016.01.013 (2016). [DOI] [PubMed] [Google Scholar]
- 56.Misra, H. P. & Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem.247 (10), 3170–3175 (1972). [PubMed] [Google Scholar]
- 57.Clairborne, A. Catalase activity. In: (ed Greewald, R. A.) Handbook of methods for oxygen radical research. Boca Raton: CRC, 283–284. (1995). [Google Scholar]
- 58.Rotruck, J. T. et al. Selenium: biochemical role as a component of glutathione peroxidase. Science179 (4073), 588–590 (1973). [DOI] [PubMed] [Google Scholar]
- 59.Jollow, D. J., Mitchell, J. R., Zampaglione, N. A. & Gillette, J. R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology11 (3), 151–169 (1974). [DOI] [PubMed] [Google Scholar]
- 60.Ohkawa, H., Ohishi, N. & Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem.95 (2), 351–358 (1979). [DOI] [PubMed] [Google Scholar]
- 61.Da Rocha, J. B. T., Aschner, M. & Nogara, P. A. Toxicology of Essential and Xenobiotic Metals. (CRC, 2024).
- 62.Ubaid, S. & Pandey, S. Metabolism of essential trace elements and associated disorders. In Clinical Applications of Biomolecules in Disease Diagnosis: A Comprehensive Guide to Biochemistry and Metabolism (205–231). (Springer, 2024). [Google Scholar]
- 63.Fontes, A. et al. Metabolic derangement of essential transition metals and potential antioxidant therapies. Int. J. Mol. Sci.25 (14), 7880. (2024). [DOI] [PMC free article] [PubMed]
- 64.Zaitseva, N. V. et al. Neurotoxic effects of aluminium and manganese’s: from molecular to clinical effects. J. Neurol. Sci.473, 123480 (2025). [DOI] [PubMed] [Google Scholar]
- 65.Anyanwu, B. O., Orish, C. N., Ezejiofor, A. N., Nwaogazie, I. L. & Orisakwe, O. E. Neuroprotective effect of Costus afer on low dose heavy metal mixture (lead, cadmium and mercury) induced neurotoxicity via antioxidant, anti-inflammatory activities. Toxicol. Rep.7, 1032–1038 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Virgolini, M. B. & Aschner, M. Molecular mechanisms lead neurotoxicity. InAdvances in Neurotoxicology (Vol. 5, 159–213). (Academic, 2021). [DOI] [PMC free article] [PubMed]
- 67.Latronico, T., Rossano, R., Miniero, D. V., Casalino, E. & Liuzzi, G. M. Neuroprotective Effect of Resveratrol against Manganese-Induced Oxidative Stress and Matrix Metalloproteinase-9 in an In Vivo Model of Neurotoxicity. Int. J. Mol. Sci.25 (4), 2142 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Kim, H., Lee, D. & Kim, K. Combined exposure to metals in drinking water alters the dopamine system in mouse striatum. Int. J. Environ. Res Public Health18 (12), 6558. (2021). [DOI] [PMC free article] [PubMed]
- 69.Zhou, F. et al. Lead, cadmium, arsenic, and mercury combined exposure disrupted synaptic homeostasis through activating the Snk-SPAR pathway. Ecotoxicol. Environ. Saf.163, 674–684 (2018). [DOI] [PubMed] [Google Scholar]
- 70.Ali, M. M., Murthy, R. C. & Chandra, S. V. Developmental and longterm neurobehavioral toxicity of low level in-utero cadmium exposure in rats. Neurobehav. Toxicol. Teratol. 8, 463–468 (1986). [PubMed] [Google Scholar]
- 71.Mansouri, M. T., Naghizadeh, B., López-Larrubia, P. & Cauli, O. Behavioral deficits induced by lead exposure are accompanied by serotonergic and cholinergic alterations in the prefrontal cortex. Neurochem Int.62, 232–239 (2013). [DOI] [PubMed] [Google Scholar]
- 72.Zhang, X. et al. Arsenic induces transgenerational behavior disorders in Caenorhabditis elegans and its underlying mechanisms. Chemosphere, 252, 126510. (2020). [DOI] [PubMed]
- 73.US EPA. Issue Paper on the Human Health Effects of Metals. (accessed 11 June 2021); https://www.epa.gov/sites/production/files/2014-11/documents/human_health_effects.pdf (2004).
- 74.Fonnum, F. & Lock, E. A. Cerebellum as a target for toxic substances. Toxicol. Lett.112, 9–16 (2000). [DOI] [PubMed] [Google Scholar]
- 75.Bazrgar, M., Goudarzi, I., Lashkarbolouki, T. & Salmani, M. E. Melatonin ameliorates oxidative damage induced by maternal lead exposure in rat pups. Physiol. Behav.151, 178–188 (2015). [DOI] [PubMed] [Google Scholar]
- 76.Ehle, A. L. & McKee, D. C. Neuropsychological effect of lead in occupationally exposed workers: a critical review. Crit. Rev. Toxicol.20 (4), 237–255 (1990). [DOI] [PubMed] [Google Scholar]
- 77.Caito, S. W. & Aschner, M. Mitochondrial redox dysfunction and environmental exposures. Antioxid. Redox. Signal.23 (6), 578–595 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Liston, C., McEwen, B. S. & Casey, B. J. Psychosocial stress reversibly disrupts prefrontal processing and attentional control. Proc. Natl. Acad. Sci.106 (3), 912–917 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Moniruzzaman, M., Chin, Y. W. & Cho, J. HO-1 dependent antioxidant effects of ethyl acetate fraction from Physalis alkekengi fruit ameliorates scopolamine-induced cognitive impairments. Cell. Stress Chaperones. 23, 763–772 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Saikia, B. et al. Zanthoxylum alatum ameliorates scopolamine-induced amnesia in rats: Behavioral, biochemical, and molecular evidence. Indian J. Pharmacol.50 (1), 30–38 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.McCord, J. M., Gao, B. & Hybertson, B. M. The complex genetic and epigenetic regulation of the Nrf2 pathways: a review. Antioxidants12 (2), 366. (2023). [DOI] [PMC free article] [PubMed]
- 82.Olufunmilayo, E. O., Gerke-Duncan, M. B. & Holsinger, R. D. Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants12 (2), 517 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Patten, D. A., Germain, M., Kelly, M. A. & Slack, R. S. Reactive oxygen species stuck in the middle of neurodegeneration. J. Alzheimers Dis.20 (s2), S357–S367 (2010). [DOI] [PubMed] [Google Scholar]
- 84.Binder, D. K. & Scharfman, H. E. Brain-derived neurotrophic factor. Growth Factors. 22 (3), 123–131 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Zuccato, C. & Cattaneo, E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat. Rev. Neurol.5 (6), 311–322 (2009). [DOI] [PubMed] [Google Scholar]
- 86.Kleim, J. A., Jones, T. A. & Schallert, T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem. Res.28 (11), 1757–1769 (2003). [DOI] [PubMed] [Google Scholar]
- 87.Ploughman, M. et al. Brain derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke40 (4), 1490–1495 (2009). [DOI] [PubMed] [Google Scholar]
- 88.Schwartz, P. M., Levy, R. L., Borghesani, P. R. & Segal, R. A. Cerebellar pathology in BDNF –/– mice: the classic view of neurotrophins is changing. Mol. Psychiatr.3 (2), 116-8 10.1038/sj.mp.4000359 (1998). [DOI] [PubMed]
- 89.Lalonde, R., Hernandez, M. & Strazielle, C. BDNF and cerebellar ataxia. Curr. Drug Res. Rev. Formerly: Curr. Drug Abuse Rev.16 (3), 300–307 (2024). [DOI] [PubMed] [Google Scholar]
- 90.Fanlo-Ucar, H., Picón-Pagès, P., Herrera-Fernández, V., Ill-Raga, G. & Muñoz, F. J. The dual role of amyloid Beta-Peptide in oxidative stress and inflammation: unveiling their connections in Alzheimer’s disease etiopathology. Antioxidants13 (10), 1208. (2024). [DOI] [PMC free article] [PubMed]
- 91.Ali, J. et al. The interplay of protein aggregation, genetics, and oxidative stress in Alzheimer’s disease: role for natural antioxidants and immunotherapeutics. Antioxidants, 13(7), p.862. (2024). [DOI] [PMC free article] [PubMed]
- 92.Costea, L. et al. The blood–brain barrier and its intercellular junctions in age-related brain disorders. Int. J. Mol. Sci.20 (21), 5472 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Xiang, J. et al. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalling’s, mediating Alzheimer’s disease pathologies. Proc. Natl. Acad. Sci.116 (18), 9094–9102 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Bendriem, R. M., Singh, S., Aleem, A. A., Antonetti, D. A. & Ross, M. E. Tight junction protein occludin regulates progenitor Self-Renewal and survival in developing cortex. Elife8, e49376 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All the data generated or analysed during this studyare included in this published article.







